On March 11, a formal complaint was submitted to US Trade Representative Jamieson Greer, urging the Trump administration to ...

Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and ...

The future of the life sciences industry hinges on AI and automation, driving innovation in drug discovery and addressing ...

Purdue is expected to raise and contribute $900m while dissolving and transforming into a new public benefit company. The non ...

By Maggie Fick LONDON (Reuters) -Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars, hoping to avert price spikes on ...

New research suggests that limiting the pharmaceutical industry’s direct-to-consumer advertising could save more money than ...

Drugmakers are urging the Trump administration and EU officials to exclude medical goods from expanding tariffs wars ...

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

US medical giants say Australia’s Pharmaceutical Benefits Scheme is an “egregious and discriminatory” program that Trump ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

New Lynx FacTOR software-as-a-service solution is designed to minimize manual processes and accelerate release cycles in the ...

Novo Nordisk rejoined the ABPI after a two-year suspension linked to promotional concerns. Audits confirmed compliance with ...